Vaccines and Immunisation Flashcards
Phases of adaptive immunity
- Antigen recognition
- Lymphocyte activation
- Antigen elimination
- Contraction (homeostasis)
- Memory
Live vaccines
Virus weakened, often by repeatedly passing virus through a tissue culture in which it replicates poorly
+ activates killer T cells
+ 1/2 doses req for lifelong immunity
- may be reactivated,less safe for people with weakened immune system
- storage, must be refrigerated
eg MMR, varicella, rotavirus
Inactivated vaccines
Pathogen treated with heat or chemicals to kill it before introduction into the body \+ low risk of causing infection \+ easy to store and transport - req several doses and boosters - elicit weaker immunological response
eg polio, hepA, rabies
Subunit vaccines
One or more parts of the pathogen such as protein is isolated and introduced to evoke immune response
+ low risk of adr
+ can be used in pt with weakened immune system
- difficult to manufacture
- may req boosters
eg. hepB, influenza, pertussis Pneumococcus
Toxoid vaccines
Toxins produced by pathogen is deactivated and introduced into the body
+ stable, easy to distribute
+ unable to cause disease or spread
- may req boosters to maintain immunity
eg diphtheria, tetanus
Recombinant vaccines
Produced using genetic engineering, may contain no actual virus or may contain modified strain of virus
eg hepB, HPV
Herd immunity
Enough of the population (depending on how contagious the disease is) is immunised to contain the spread of the disease and most community members are protected, including the unimmunised indiv
Vaccines for respiratory (airborne or droplet) transmitted infection (9)
influenze, pneumococcus, meningococcus, diphtheria, pertussis, hemophilus influenzae (bacteria), mmr, chicken pox, bsg
Vaccines for contact transmitted infection (3)
tetanus, rabies, shingles
General considerations in vaccine use
Effectiveness, AE, CI and precautions, simultaneous adm
Vaccines for food and water transmitted infection
hepA, typhoid, cholera, rotavirus
Vaccines for vector borne transmitted infection
yellow fever, japanese encephalitis dengue, malaria
Effective of vaccines consideration
Varies by vaccine eg hepB 95% effective, var 90%
Other factors:
Site given (hepA/B in deltoid and not gluteus)
Pt age and immune status (inf less effective in 80 vs 60)
cold chain problems (not kept at recommended temp)
AE of vaccines
General:
- mild and common: pain at injection site, headache, myalgia
- uncommon: fever, hematoma
- severe but rare: anaphylaxis, hypersensitivity
CI/precautions of vaccines
- Fever, may not be able to mount immune response
- pregnancy
- immunocompromised
- allergy to vaccines or components
- bleeding risk (on anti-coagulaiton or low platelet counts) - precaution